Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for heart transplantation Ulrik Sartipy, MD, PhD, Ayumi Goda, MD, Melana Yuzefpolskaya, MD, Donna M. Mancini, MD, Lars H. Lund, MD, PhD American Heart Journal Volume 168, Issue 3, Pages 325-331 (September 2014) DOI: 10.1016/j.ahj.2014.03.025 Copyright © 2014 Mosby, Inc. Terms and Conditions
Figure 1 Event-free survival for SHFM risk strata. Kaplan-Meier event-free survival for SHFM low-, medium-, and high-risk strata in 382 patients with CRT and/or ICD referred for heart transplantation. American Heart Journal 2014 168, 325-331DOI: (10.1016/j.ahj.2014.03.025) Copyright © 2014 Mosby, Inc. Terms and Conditions
Figure 2 Observed versus predicted event-free survival. Observed versus SHFM-predicted event-free survival at 1, 2, and 3 years in low-, medium-, and high-risk strata in 382 patients with CRT and/or ICD referred for heart transplantation. American Heart Journal 2014 168, 325-331DOI: (10.1016/j.ahj.2014.03.025) Copyright © 2014 Mosby, Inc. Terms and Conditions
Figure 3 Calibration plot. Calibration plot showing the mean predicted probability of event-free survival against the observed proportion of event-free survival for the calculated SHFM integer score at 1, 2, and 3 years. The dashed line shows the ideal calibration line. American Heart Journal 2014 168, 325-331DOI: (10.1016/j.ahj.2014.03.025) Copyright © 2014 Mosby, Inc. Terms and Conditions
Figure 4 Seattle Heart Failure Model score and predicted and observed survival. Distribution of the calculated SHFM integer score and its relationship to the predicted and observed survival in 382 patients with CRT and/or ICD referred for heart transplantation. American Heart Journal 2014 168, 325-331DOI: (10.1016/j.ahj.2014.03.025) Copyright © 2014 Mosby, Inc. Terms and Conditions